Healthequity (NASDAQ:HQY) updated its FY 2020 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of $1.23-1.29 for the period, compared to the Thomson Reuters consensus estimate of $1.31. The company issued revenue guidance of $333-339 million, compared to the consensus revenue estimate of $336.33 million.
A number of equities research analysts have weighed in on the stock. Cantor Fitzgerald upped their price target on shares of Healthequity from $80.00 to $83.00 and gave the company an overweight rating in a report on Thursday, February 7th. BidaskClub raised shares of Healthequity from a hold rating to a buy rating in a report on Saturday, December 1st. Citigroup set a $102.00 price target on shares of Healthequity and gave the company a buy rating in a report on Tuesday, January 8th. Wells Fargo & Co cut their price target on shares of Healthequity from $100.00 to $90.00 and set an outperform rating for the company in a report on Friday, December 7th. Finally, Zacks Investment Research downgraded shares of Healthequity from a hold rating to a sell rating in a report on Wednesday, February 27th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, eleven have given a buy rating and one has given a strong buy rating to the stock. The stock presently has an average rating of Buy and a consensus price target of $87.85.
HQY stock traded up $0.71 during mid-day trading on Monday, reaching $82.87. 1,083,638 shares of the stock traded hands, compared to its average volume of 871,417. Healthequity has a 52-week low of $50.29 and a 52-week high of $101.58. The firm has a market capitalization of $5.10 billion, a PE ratio of 153.46, a P/E/G ratio of 2.68 and a beta of 1.72.
In other Healthequity news, EVP Delano Ladd sold 6,875 shares of the company’s stock in a transaction dated Wednesday, February 20th. The shares were sold at an average price of $78.00, for a total transaction of $536,250.00. Following the completion of the sale, the executive vice president now directly owns 14,340 shares of the company’s stock, valued at $1,118,520. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, VP Darcy G. Mott sold 4,000 shares of the company’s stock in a transaction dated Wednesday, February 20th. The shares were sold at an average price of $77.87, for a total transaction of $311,480.00. Following the sale, the vice president now directly owns 74,000 shares of the company’s stock, valued at $5,762,380. The disclosure for this sale can be found here. Insiders have sold 18,875 shares of company stock valued at $1,332,090 over the last ninety days. Insiders own 4.00% of the company’s stock.
COPYRIGHT VIOLATION WARNING: “Healthequity (HQY) Releases FY 2020 Earnings Guidance” was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece of content on another domain, it was stolen and reposted in violation of United States and international trademark & copyright law. The legal version of this piece of content can be read at https://www.dispatchtribunal.com/2019/03/18/healthequity-hqy-releases-fy-2020-earnings-guidance.html.
Healthequity Company Profile
HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
See Also: Why is the Consumer Price Index (CPI) important?
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.